1. Executive Summary

Three-sentence thesis. Resideo is a misunderstood two-part conglomerate trading at ~8x forward adjusted EBITDA and a ~9-10% normalized free-cash-flow yield, where the reported FY2025 GAAP net loss of -$527M and -$1.14B operating cash flow are entirely the artifact of a single, hugely value-accretive August 2025 transaction: a $1,590M cash payment to permanently extinguish a legacy Honeywell environmental-indemnity liability that had been draining ~$140M of cash and ~$180-210M of reported pre-tax income every year. With that liability gone and a tax-free spin-off of the low-margin ADI Global Distribution business expected to complete between mid-Q3 and mid-Q4 2026, the market is being handed a clean catalyst to re-rate two pure-play companies — a high-margin (20%+ segment-operating-margin) branded building-products manufacturer (Honeywell Home, First Alert, BRK, Braukmann) and a $4.8B specialty distributor — that are jointly cheaper than the sum of their parts. The stock is down ~30% from its 52-week high and ~23% in the past month on macro/freight-cost worries, which is precisely why a disciplined buyer can accumulate quality below intrinsic value with a hard near-term catalyst.

2. Opportunity Identification (Klarman) — Why is this cheap?

This is a textbook "complexity + optics + forced-selling-adjacent" mispricing, with three distinct drivers:

1. Headline GAAP optics are catastrophic and misleading. FY2025 shows a -$527M net loss and -$1,137M operating cash flow. A screen sorting on GAAP P/E, ROE, or FCF flags REZI as a money-loser. In reality, the entire distortion is one line: Indemnification Agreement expense of $972M in 2025 (10-K Note 4), the loss on terminating the Honeywell environmental liability, and the $1,590M one-time cash payment to do so (10-K MD&A). Strip that out and the company earned ~$627M of core operating income and generated ~$453M of operating cash flow (management's "adjusted cash from operations"). The market is anchoring on the wound, not the cure.

2. Conglomerate discount on two non-obviously-related businesses. A branded thermostat/safety manufacturer (P&S) and a low-voltage security/AV distributor (ADI) sit under one ticker. Generalists can't decide whether REZI is an industrial, a distributor, or a smart-home play, so it gets neither a manufacturer's multiple nor a distributor's multiple. The announced tax-free spin (Form 10 filed) is the classic Klarman catalyst that forces the parts to be valued separately.

3. Macro/cyclical fear and recent technical weakness. Soft US housing, residential-HVAC channel destocking (now ending), high-end residential AV softness at ADI, and freight/fuel cost inflation have compressed sentiment. The stock fell ~23% in the last month. Greenlight's new position (Q1 2026) suggests at least one disciplined value buyer sees the same gap.

Conclusion: I can clearly articulate why this is cheap. That is a green light to proceed (Klarman: "if I cannot explain why it is cheap, stop").

3. Business Model (from management's own words and the 10-K)

Resideo operates two reportable segments plus Corporate:

Products and Solutions (P&S) — the future "RemainCo" Resideo.

• A leading residential controls and sensing manufacturer: temperature/humidity control, water and air solutions, smoke and carbon-monoxide detection, residential/small-business security, video cameras, plus components sold to OEMs of water heaters, heat pumps, and boilers.
• Brands: Honeywell Home (licensed), First Alert, BRK, Braukmann, Resideo.
• FY2025: revenue $2,688M, segment income from operations $555M (20.6% margin), up from $503M (2024) and $446M (2023). 12 consecutive quarters of YoY gross-margin expansion (Q1 2026 call). This is the high-quality crown jewel.

ADI Global Distribution — to be spun off.

• Global specialty distributor of professionally installed low-voltage products (security, AV, datacomm), selling to ~75,000+ licensed installers/integrators through an omnichannel platform. Absorbed the ~$1B Snap One acquisition (closed 2024; Control4, Luma, Triad, Araknis exclusive brands).
• FY2025: revenue $4,784M, segment income from operations $212M (4.4% margin), vs $195M (2024) and $238M (2023). A classic low-margin, scale/route-density distributor; cyclically exposed to residential AV.

Revenue bridge FY2025 (+$711M, +10.5%): +$446M Snap One, +$193M price/mix, +$47M volume, +$32M FX (10-K MD&A).

4. Phase 1 — Risk Analysis (Inversion)

"All I want to know is where I'm going to die, so I'll never go there." — Munger

4.1 How could this lose 50%+ permanently?

1. Leverage + cyclical downturn. Net debt is $2.57B (2.7x 2026E adj EBITDA). The $2.33B term loan floats at SOFR + 2.00%. A severe housing/construction recession that knocks adj EBITDA from ~$960M toward ~$650M would push leverage toward ~4x, interest coverage toward ~3x, and crush equity value given the fixed claims (debt + $0.5B preferred) ahead of common. This is the single biggest permanent-loss risk.
2. Spin destroys rather than creates value. Dis-synergies, stranded corporate costs, two sub-scale balance sheets, and the residual Honeywell trademark constraint (below) could mean 1 + 1 < 2. If post-spin "RemainCo" Resideo is loaded with most of the debt and ADI is set free under-capitalized (or vice versa), the common holder of today's REZI could be left holding the weaker entity.
3. Honeywell trademark agreement is terminable on an unapproved change of control. REZI pays Honeywell a 1.5% royalty on net revenue of Honeywell Home branded products under a 40-year Trademark License Agreement (10-K, accounting policy (o)). Honeywell can terminate it if REZI breaches material obligations, and it automatically terminates on a non-Honeywell-approved change of control or if a subsidiary ceases to be wholly owned. This both caps acquisition optionality and creates a recurring cost and a tail dependency on a third party for the most valuable brand in the P&S portfolio.

4.2 Risk register (probability x impact)

Tail risk (non-additive): a 2008-style construction collapse coinciding with the spin and refinancing the floating-rate term loan into a high-rate environment is the lollapalooza scenario — leverage, cyclicality, and refinancing risk compounding. Mitigant: ~70% of P&S is replace-on-failure safety/comfort (smoke/CO detectors, thermostats, boilers) with a meaningful repair/remodel and code-driven (non-discretionary) demand component, which dampens the cyclical trough.

4.3 Pre-defined sell triggers (non-price)

• Net debt / adj EBITDA breaches 4.0x without a clear de-lever path.
• P&S gross-margin-expansion streak reverses for two consecutive quarters (moat erosion signal).
• Spin terms allocate the debt punitively to the entity carrying the high-quality P&S business.
• Honeywell initiates termination of the Trademark Agreement.

4.4 Three-sentence bear case (stated better than the bears)

Resideo is a levered, low-organic-growth (3-4%) collection of mature, housing-cyclical businesses whose "record" 2025 was flattered by the Snap One acquisition and a one-time accounting benefit, and whose ADI distribution arm — half the revenue — earns a structurally thin 4% margin in a residential-AV market in secular decline. The spin-off is financial engineering that creates two sub-scale companies, each saddled with ~3x leverage, a 7% participating preferred ahead of common, and a perpetual 1.5% royalty leash to Honeywell on its best brand. Strip away the optics and you are paying ~8x EBITDA for a business that has produced a -2.8% five-year total return since its 2018 spin and whose normalized GAAP EPS ($1.92) is roughly 40% below the adjusted number management asks you to believe.

5. Phase 2 — Financial Analysis

5.1 Earnings power, normalized (this is the crux)

Reported GAAP is dominated by the Honeywell event. The reconciliation from the 10-K (Note 4) is decisive:

Two things jump out:

• The Indemnification Agreement expense was a recurring drag of $178-211M every year even before the 2025 termination charge. That cost is now permanently zero. All else equal, normalized pre-tax income improves by ~$200M/year going forward — a structural earnings step-up the GAAP series obscures.
• Core operating income (segment ops less corporate SG&A and restructuring, before the indemnity line) was ~$627M in 2025 and growing.

Normalized owner economics (whole company, post-termination):

• Core EBIT $627M; full-year interest on $3.23B debt ~$198M (term loan ~6.3%, $300M @ 4.0%, $600M @ 6.5%); pre-tax ~$429M; at ~24% tax, ~$326M net income; less $35M preferred dividend = ~$291M to common = **$1.92 normalized GAAP EPS (basic)**.
• This is below management's 2026 adjusted diluted EPS guide of $3.00-3.20; the gap is intangible amortization (~$120M, heavily Snap One purchase accounting — a non-cash item that overstates the economic cost), stock comp, separation, and restructuring add-backs. Reality sits between: economic owner earnings are ~$2.50-3.00/share once you give partial credit for non-cash amortization on acquired intangibles that do not require cash reinvestment to maintain.

5.2 Free cash flow (the cleanest anchor)

• Reported 2025 OCF -$1,137M = normalized $453M minus the $1,590M Honeywell payment. Management's "adjusted cash from operations" of $453M reconciles exactly.
• 2026E FCF to equity: adj EBITDA $960M - capex ~$130M - cash interest ~$198M - cash tax ~$120M = ~$512M; less ~$35M preferred = **$477M to common ≈ $3.00/share basic ≈ 9.6% FCF yield at $31.21**.
• The Honeywell termination is cash-flow neutral-to-positive going forward: it removes up to $140M/year of indemnity cash payments and adds ~$77M/year of incremental interest on the $1.225B of new debt — a net swing in the company's favor of roughly $60M/year, before the optics benefit.

5.3 Returns on capital

• Pre-distortion (2021-2024), the business generated $116-283M net income on ~$2.3-3.3B equity — mid-single-digit to low-double-digit ROE, depressed by the indemnity drag and the goodwill/intangible-heavy balance sheet (Snap One + First Alert acquisitions loaded ~$3B+ goodwill/intangibles).
• The economically relevant metric is ROIC on the P&S manufacturing business, which earns 20.6% segment operating margins on a modest tangible asset base — a genuinely high-return franchise. ADI is a thin-margin, high-asset-turn distributor whose ROIC is acceptable but unexceptional. The blended consolidated ROIC (~8-10% normalized) understates the quality of the half worth owning.

5.4 Valuation (Trinity + DCF + SOTP)

A. Sum-of-the-parts (the spin makes this the primary lens):

B. DCF (consolidated unlevered FCF ~$560M base, 5% near-term growth, sensitivity):

Given beta ~1.65 and leverage, I weight the 9.5-10% WACC outcomes -> ~$35-43.

C. FCF-yield / multiple cross-check: $3.00 normalized FCF/share. At a 7% FCF yield (14x) -> $43; at 8.5% (12x) -> $35.

Valuation summary table:

Fair value range: $36-44; central estimate ~$40. Margin of safety at $31.21 is ~22% to the midpoint. With a hard catalyst (the spin), 20% MOS clears the framework's bar for a standard position; it does not yet clear the 30%+ "strong buy" bar.

6. Phase 3 — Moat Analysis

Verdict on moat: NARROW overall, but bifurcated. P&S is the durable franchise — 12 consecutive quarters of gross-margin expansion is hard evidence of pricing power and operating discipline, and category-leading safety brands (First Alert/BRK) enjoy code-mandated, replace-on-failure demand. ADI is a competent but commodity-economics distributor whose moat is scale and service, not pricing power. The key dependency is the licensed Honeywell Home brand: powerful but rented (1.5% royalty, 40-year term, change-of-control termination). A wholly-owned brand would be a wider moat; a licensed one is a narrower, conditional moat. The moat is wider for the half (P&S) you keep after the spin and narrower for the half (ADI) you receive as a separate stock — which is itself an argument for the spin.

7. Phase 4 — Management & Incentives

• CEO Jay Geldmacher (since 2018, the spin) has executed a credible operational turnaround: P&S margins from ~17% (2023) to 20.6% (2025), ERP stabilization at ADI, $75M Snap One synergies delivered 18 months early.
• Capital allocation, recent record:
  • Snap One acquisition (2024, ~$1.4B incl. the $500M CD&R preferred): strategically logical (folds into ADI) but bought into a softening residential-AV cycle; revenue has declined since close. Jury still out; synergy delivery is the redeeming feature.
  • First Alert acquisition (2022, ~$593M): strong fit, gave P&S the #1 US smoke/CO safety brand; looks like a good deal.
  • Honeywell indemnity termination (Aug 2025, $1,590M): the standout capital-allocation decision. Paying $1.59B to retire a liability capped at $140M/year running to 2043 removes a perpetual cash and earnings drain, simplifies the equity story, and is value-accretive at any reasonable discount rate (PV of ~$140M/yr for ~18 yrs at 8% ≈ $1.3B, but the accounting liability and risk-removal/optionality justify the premium and the simplification ahead of the spin).
  • Buybacks: $150M authorization (2023); zero repurchased in 2025 (correctly conserving cash for de-levering). Appropriate given leverage.
• The spin is the defining capital-allocation move — management explicitly frames it as "another catalyst for a multiple rerating." Incentives appear aligned with value realization rather than empire-building.
• Overhang — Series A preferred: $500M, 7% participating cumulative convertible held by CD&R, conversion at $26.92 (in the money). It is both a dilution overhang (~18.6M as-converted shares, ~11% of diluted) and a sophisticated-investor vote of confidence. Watch how it is treated in the spin.

8. Phase 5 — Catalysts

This is a catalyst-rich situation, which materially de-risks the time dimension (Klarman) and justifies a 20% (vs 30%) MOS requirement.

9. Phase 6 — Decision Synthesis

9.1 Expected-return probability tree (2-3 year horizon)

A ~25% probability-weighted 2-3 year return, anchored by a hard structural catalyst, is attractive though not extraordinary; the leverage and ADI cyclicality cap the conviction.

9.2 Position sizing

Quality (bifurcated, narrow moat, B+), ~22% MOS, strong catalyst, but elevated leverage and high beta -> standard-to-half position, 1.5-2.5% of portfolio, with room to add aggressively below ~$27 (where MOS exceeds 30% and the preferred conversion price provides a soft floor).

9.3 Recommendation

RECOMMENDATION: ACCUMULATE
Current price:   $31.21
Fair value:      ~$40 (range $36-44)
Strong Buy:      <= $27   (>30% MOS; near preferred conversion floor $26.92)
Accumulate:      <= $33   (~20% MOS; current zone)
Trim/Fair:       ~$44-48
Position size:   1.5-2.5% (standard-to-half)
Primary catalyst: ADI tax-free spin-off, mid-Q3 to mid-Q4 2026
Primary risk:    Financial leverage (~2.7x) into a housing-cyclical downturn
Sell trigger:    Net debt/EBITDA > 4.0x w/o de-lever path; P&S GM streak reverses 2Q; punitive spin debt allocation

9.4 Munger psychology check

• Social proof caution: Einhorn's purchase is corroboration, not the thesis — my own SOTP and the Honeywell-termination earnings step-up stand on their own.
• Deprival/availability: the -23% month is a reason to look, not a reason to buy; value vs. price is the test, and price < value by ~22%.
• If it dropped 50% tomorrow on no fundamental change: I would buy more — the P&S franchise and the preferred conversion floor make that an asymmetric add. That is the right answer (proceed).

10. Citations

• Resideo FY2025 10-K (filed 2026-02-24), Notes 4, 11, 15, 16; MD&A. data/sec/10-K-2025.htm / .txt.
  • $1,590M Honeywell payment, $1,225M incremental term loans (MD&A Liquidity).
  • Segment table: P&S rev $2,688M / op $555M; ADI rev $4,784M / op $212M; Indemnification expense $972M (2025), $211M (2024), $178M (2023); total debt $3,231M.
  • Indemnification Agreement cap $140M/yr, to 2043, terminated Aug 2025.
  • 40-year Trademark Agreement, 1.5% royalty (policy note o).
  • Series A preferred: $500M, 7%, conversion price $26.92, CD&R/Snap One financing.
• FY2024 10-K (filed 2025-02-20): data/sec/10-K-2024.htm.
• Q1 2026 10-Q (filed 2026-05-12): data/sec/10-Q-Q1-2026.htm.
• Earnings transcripts Q1 2026 and Q4/FY 2025 (AlphaVantage): data/earnings-transcript-*.md.
• AlphaVantage COMPANY_OVERVIEW, INCOME_STATEMENT, BALANCE_SHEET, CASH_FLOW (11yr): data/*.json, processed data/financial-summary.md.
• Prices (1,920 daily records): data/historical-prices.json, processed data/price-summary.md ($31.21, beta 1.65, 52w $20.54-$44.50).